Evotec SE Share Price Other OTC
Stocks
EVTCY
US30050E1055
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 855M 971M 789M 738M 1.38B 91.54B 1.41B 9.48B 3.67B 45.15B 3.65B 3.57B 157B | P/E 2026 * |
-6.62x | P/E 2027 * | -24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 869M 987M 802M 750M 1.41B 93.07B 1.43B 9.64B 3.73B 45.91B 3.71B 3.63B 160B | EV / Sales 2026 * |
1.18x | EV / Sales 2027 * | 1.13x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evotec SE
| 1 day | +1.30% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/06/2024 | |
| Director of Finance/CFO | - | 30/04/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 30/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 18/06/2019 |
| Director/Board Member | 64 | 31/05/2021 | |
| Director/Board Member | 43 | 21/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | -.--% | - | - | 951M | |
| +2.56% | +7.12% | -7.30% | +1.26% | 44.45B | |
| +0.15% | +7.61% | +324.11% | +582.63% | 36.04B | |
| +0.36% | +5.50% | +3.87% | +53.88% | 30.7B | |
| +8.37% | +8.76% | +17.05% | -13.19% | 28.59B | |
| +7.60% | -1.03% | +14.05% | +20.82% | 23.01B | |
| -0.24% | +2.97% | - | - | 14.82B | |
| +8.30% | +12.19% | +62.65% | +127.80% | 13.52B | |
| +2.73% | +7.16% | +11.00% | +19.38% | 12.98B | |
| +0.70% | +2.97% | +93.04% | +95.70% | 12.56B | |
| Average | +3.13% | +2.88% | +64.81% | +111.03% | 24.07B | |
| Weighted average by Cap. | +3.12% | +3.11% | +71.56% | +128.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 738M 838M 680M 636M 1.19B 78.97B 1.21B 8.18B 3.17B 38.96B 3.15B 3.08B 136B | 818M 929M 754M 706M 1.32B 87.56B 1.35B 9.07B 3.51B 43.19B 3.49B 3.41B 150B |
| Net income | -113M -129M -104M -97.68M -183M -12.12B -186M -1.26B -486M -5.98B -483M -472M -20.81B | -30.42M -34.55M -28.06M -26.24M -49.17M -3.26B -50.09M -337M -131M -1.61B -130M -127M -5.59B |
| Net Debt | 14.3M 16.24M 13.19M 12.34M 23.11M 1.53B 23.55M 159M 61.4M 755M 60.98M 59.66M 2.63B | 69.32M 78.74M 63.94M 59.81M 112M 7.42B 114M 768M 298M 3.66B 296M 289M 12.74B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
